The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...

Q1 earnings per share at $2.22 vs forecast at $2.14 a share World sales dip 2% to $15.5 billion vs forecast $15.3 billion Sales of Gardasil fall 41% to $1.3 billion For the full year, Merck ...

Halozyme (HALO) filed a patent infringement lawsuit against Merck (MRK) in U.S. District Court in New Jersey. Halozyme believes the subcutaneous formulation of Merck’s cancer medicine ...

The parties are in discussion on the basis of a price of around USD 47 per share. Merck notes that no final decision has been taken and no legally binding agreement has been entered into.

(Reuters) -Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, reflecting a January decision to pause shipments of its Gardasil ...

(Reuters) -Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, reflecting a January decision to pause shipments of its Gardasil vaccine ...

Merck is scheduled to release its earnings report on Thursday, April 24, 2025. Historical data suggests that MRK stock often reacts negatively to such announcements. Over the past five years, the ...

MLB.com reported that the team will add the player’s No. 21 logo back to the right field wall at PNC Park after it was removed to place an advertisement on the space. The logo has been in ...

Merck unveiled encouraging Phase 3 KEYNOTE-689 trial results for KEYTRUDA at the AACR 2025 Meeting, sparking investor ...

All products featured on WIRED are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission. Sensor doesn’t capture ...